INTRODUCTION
Malignancies of the head/neck (HN), especially the squamous cell carcinomas (SCCs) cancers arising in the oral cavity, are common in India and constitute a major public health problem. Most common ways of the spread for carcinomas in HN is by lymphatic route and in few cases hematogenous. Some tumors however have a propensity to spread to a distant site through perineural route. The exact reason for this phenomenon is presently unclear; probably the nerve appears to form a natural channel and conduit of least resistance along the otherwise "difficult-to-traverse" complex HN anatomy.
Perineural spread (PNS) in HN malignancies implies a grave prognosis with poor event-free and overall survival in patients with SCC compared to those without it. [1] [2] [3] PNS is more Common patterns of perineural spread in head-neck squamous cell carcinoma identified on fluoro-deoxy-glucose positron emission tomography/computed tomography Pathological anatomy of perineural spread Commonly involved cranial nerves in PNS are mandibular division of trigeminal nerve (V3), maxillary nerve (V2), facial nerve (VII), and hypoglossal nerve (XII) due to their long extensive course in the HN region. The anatomical knowledge of the course of these nerves is essential in the clinicoradiological diagnosis of PNI [ Table 1 ]. [6] V2 nerve is usually involved by direct invasion though tumors in the upper lip or malar surface and tumors of nasopharynx or palate though the palatine nerves [ Figure 1 ]. V3 nerve is usually involved by the tumors in the lower lip/alveolus spreading through inferior alveolar nerve, or parotid/infratemporal fossa tumors spreading via the auriculotemporal branch [ PNS along facial (VII) nerve is usually involved by tumors of parotid glands, extending into the stylomastoid foramen and temporal bone. PNS along hypoglossal nerve (XII) involvement is seen with tumors of the tongue base and nasopharyngeal tumors [Figures 7 and 8] . Due to close proximity of the branches of these nerves, simultaneous multiple cranial nerve involvement in is not uncommon [ Figure 5 ].
Magnetic resonance imaging in diagnosis of perineural spread
PNS is best and earliest detected with a contrast-enhanced T1-fat suppressed magnetic resonance (MR) sequences. Due Arises from the trigeminal ganglion, courses anteriorly in lateral wall of cavernous sinus and passes through foramen rotendum, through the upper part of pterygopalatine fossa, then enters orbit through inferior orbital fissure and exits orbit through infraorbital foramen as infraorbital nerve Mandibular (V3) Arises from the trigeminal ganglion, exits the skull through foramen ovale, then enters the infra-temporal fossa supplying the muscles of mastication, then dividing into anterior trunk (lingual nerve) and posterior trunk (inferior alveolar nerve) Facial (VII)
Emerges from the brain stem, and continues into the internal acoustic meatus, then runs posterior to geniculate ganglion, into the tympanic segment in the medial wall of middle ear cavity, makes a bend exiting the skull though the stylomastoid foramen, passes between post belly of digastric and stylohyoid to lie between the deep and superficial lobes of parotid finally dividing into 5 main braches supplying facial muscles Hypoglossal (XII) Originating from the medulla, nerve enters the hypoglossal canal, passes obliquely downwards between the internal jugular and internal carotid artery, then runs forward, crossing the loop at the origin of lingual artery, then passing superficial to the hyoglossus muscle, and forward into the tongue supplying all the muscles except palatoglossus to break in the blood-nerve barrier caused by the tumor, the enhancement of the nerve precedes the nerve enlargement. Further proliferation of the tumor leads to the replacement of the perineural fat and widening/erosion of foramen in skull bases. The nerve invasion by tumor may be seen as a continuous nerve enhancement or skip lesion at a distant site in nerve probably through perineural lymphatics. Indirect features of nerve involvement like muscle denervation seen as hyperintense T2 signals in the muscle secondary to edema can supplement the MR diagnosis of PNS [ Figure 8 ]. [7] 
P o s i t r o n e m i s s i o n t o m o g r a p h y / c o m p u t e d tomography for diagnosis of perineural spread
The use of PET/CT in HNSCC is increasing. Superior diagnostic accuracy PET/CT over conventional morphological imaging has been established, especially for evaluating nodal and distant metastasis, to assess disease recurrence, assessing response to curative chemoradiotherapy or neo-adjuvant chemotherapy, and predicting treatment outcomes. [8] Detection of PNS of tumor on PET/CECT is not uncommon. Use of diagnostic quality CT, i.e., contrast-enhanced, high mA with thin bone window CT sections in the PET/CT protocol is of prime importance in diagnosing PNS in HNSCC. [9] CT reconstruction parameters used at our institute for HN region includes slice thickness of 0.67 mm, field of view of 250 mm, window -35 × 350, increment -0.33 mm, and matrix of 512. About 80 ml of low osmolar nonionic intravenous contrast is administered in all patients at a rate of 1.8 ml/s and scan delay is usually about 50-60 s.
Care should be taken to avoid frequent false negative/false positive interpretations on PET/CECT in HNSCC cases. The uptake intensity along the nerve course may be subtle leading to false negative scan, probably attributed to tumor biology (less uptake in salivary gland and necrotic neoplasm), improper PET/CT image co-registration, partial volume effect for smaller lesions (<1 cm), or high adjacent background activity in brain [ Figure 6 ]. False positive scans can be seen in setting such as postradiotherapy/postoperative inflammation, asymmetric physiological FDG uptake in the facial muscles, hyper-enhancing primary neural tumors (schwannoma/ meningiomas) [ Figure 9 ], invasive fungal infections, and dental abscesses. Careful assessment of the patients' history, clinical features, and assessment of correlative imaging can help avoid such pitfalls. [10] [11] [12] [13] 
Positron emission tomography/magnetic resonance for detection of perineural spread
Feasibility of clinical PET/MR for imaging HN tumors has been suggested by few studies. [14, 15] In addition to providing significantly less radiation exposure to the patient, this modality appears to have a higher spatial resolution, due to reduced partial volume effects and lesser chance of signal loss that is seen with small structures in HN. [14] This will translate into higher target to background contrast, further enhancing detection of PNS in HN SCC compared to that provided by the existing PET/ CT systems. Clinical presentation is usually delayed due to lack of symptoms and diagnosis is very often confirmed on imaging. MR imaging is the gold standard for identification of PNS and outperforms the diagnostic accuracy of CECT or PET/CT for this indication. With recent exponential increase in the use of PET/CT in HNSCC, identifying clinically occult PNS on PET/CT is not uncommon, thereby complementing MR in diagnosis and potentially obviating further diagnostic interventions. A precise knowledge of clinical presentation, regional anatomy, and correlative imaging is, however, a prerequisite and which may help the nuclear medicine physician in avoiding image misinterpretations. This would improve the reporting accuracy of PET/CT and along with recent advances in technology such as PET/MR would together promote molecular imaging toward being a "standard of care" in diagnostic evaluation of HN malignancies. 
